Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
166.00
0.00 (0.00%)
Feb 25, 2026, 4:00 PM EST
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $323.85 billion as of February 27, 2026. Its market cap has increased by 52.60% in one year.
Market Cap
323.85B
Enterprise Value
348.96B
Revenue
56.67B
Ranking
n/a
PE Ratio
23.16
Stock Price
$166.00
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 323.85B, an increase of 154.31%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 323.85B | 21.75% |
| Dec 30, 2025 | 266.00B | 36.05% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Glass House Brands | 732.03M |
| Veradigm | 731.05M |
| Elite Pharmaceuticals | 436.14M |
| American Oncology Network | 389.18M |
| Northwest Biotherapeutics | 374.17M |
| CytoDyn | 329.61M |
| OpGen | 297.15M |